|
Whole Body Hyperthermia and Anti-Tumor Immune Response
|
5R01CA071599-10
|
$283,824
|
$28,382
|
REPASKY, ELIZABETH
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Viral and Cellular Determinants of Hepatitis B Virus Pathogenesis
|
5R01CA056533-16
|
$423,021
|
$423,021
|
Schneider, Robert
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
VEGI-192 As An Anticancer Therapeutic Agent
|
5R01CA113875-03
|
$228,476
|
$57,119
|
LI, LUYUAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
VEGFs in Artery-Vein Imbalance in AIDS-Kaposi Sarcoma
|
5R01CA079218-09
|
$328,425
|
$16,421
|
Gill, Parkash
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-35S1
|
$59,955
|
$1,199
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-35
|
$4,795,480
|
$95,910
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-20
|
$1,758,769
|
$17,588
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Use p105(sr) to study p50 homodimer in skin tumor/cancer
|
5R01CA104912-05
|
$203,349
|
$50,837
|
LIN, LI
|
MEDSTAR RESEARCH INSTITUTE
|
|
Unusual Regulation of the NF-kappaB/IKK Pathway by Ras
|
5R01CA073756-10
|
$249,182
|
$24,918
|
BALDWIN JR, ALBERT
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Ultraviolet-Induced Signal Trasduction
|
5R01CA077646-09
|
$236,453
|
$23,645
|
DONG, ZIGANG
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Tyrosine Protein Kinases and Lymphocyte Activation
|
5R01CA037372-25
|
$243,999
|
$80,520
|
GEAHLEN, ROBERT
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
|
Tumor Necrosis Factor-alpha Signaling in Breast Cancer
|
3R01CA071727-08S1
|
$43,952
|
$43,952
|
Basu, Alakananda
|
UNIVERSITY OF NORTH TEXAS HLTH SCI CTR
|
|
Tumor Necrosis Factor-alpha Signaling in Breast Cancer
|
5R01CA071727-08
|
$223,842
|
$223,842
|
Basu, Alakananda
|
UNIVERSITY OF NORTH TEXAS HLTH SCI CTR
|
|
Tumor models for the study of inflammation and oncogenesis
|
Z01 BC 010893
|
$203,062
|
$40,613
|
Wiltrout, Robert
|
CCR (NCI)
|
|
Tumor Gangliosides and TNF Synergize for T Cell Death
|
5R01CA111917-04
|
$257,865
|
$257,865
|
TANNENBAUM, CHARLES
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Treatment of Infections in Immunocompromised Children
|
Z01 SC 006830
|
$1,957,171
|
$587,151
|
Walsh, Thomas
|
CCR (NCI)
|
|
Training Program in Molecular Oncology and Immunology
|
5T32CA009161-34
|
$556,042
|
$55,604
|
PELLICER, ANGEL
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
TRAIL-induced Cell Death in Breast Cancer Cells
|
Z01 SC 007263
|
$324,990
|
$129,996
|
Lipkowitz, Stanley
|
CCR (NCI)
|
|
TRAIL Therapy for Rhabdomyosacrcoma
|
5R01CA087952-07
|
$234,840
|
$117,420
|
HOUGHTON, JANET
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
TRAIL Receptor Signaling in Human Tumors
|
1R01CA124545-01A1
|
$413,398
|
$206,699
|
THORBURN, ANDREW
|
UNIVERSITY OF COLORADO DENVER
|
|
TNF Alpha in PKC Epsilon Signaling to Carcinogenesis
|
5R01CA102431-05
|
$254,537
|
$254,537
|
VERMA, AJIT
|
UNIVERSITY OF WISCONSIN MADISON
|
|
The Role of Non-Hematopoietic Cells in Tumor Tolerance Induction
|
1K08CA131097-01
|
$120,606
|
$30,152
|
krupnick, Alexander
|
WASHINGTON UNIVERSITY
|
|
The NF-kB Target, Gadd45Beta, in Lymphocytes and Liver
|
7R01CA084040-09
|
$217,607
|
$54,402
|
FRANZOSO, GUIDO
|
U OF L IMPERIAL COL OF SCI/TECHNLGY/MED
|
|
The Molecular Mechanism of TNF-induced Necrotic Cell Death
|
Z01 BC 010783
|
$262,003
|
$262,004
|
Liu, Zheng-Gang
|
CCR (NCI)
|
|
The Immunobiology of Marrow Allografts for Leukemia
|
5P01CA023766-30
|
$2,959,846
|
$147,992
|
O'REILLY, RICHARD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Targeting GITR for Tumor Immunotherapy
|
5K08CA127143-02
|
$138,243
|
$138,243
|
COHEN, ADAM
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Targeting Deceoy Receptor 3 in Breast Cancer
|
1R43CA128176-01A2
|
$335,322
|
$335,322
|
Kim, Sunghee
|
BIOPOWERTECH
|
|
Targeted polymeric nanocarriers for combination therapy of prostate cancer
|
1R21CA132033-01
|
$164,470
|
$82,235
|
Forrest, Marcus
|
UNIVERSITY OF KANSAS LAWRENCE
|
|
Targeted antigen receptor treatment of cancer
|
5P01CA033049-25
|
$2,161,758
|
$216,176
|
SCHEINBERG, DAVID
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
T Cell Memory
|
Z01 BC 010932
|
$215,977
|
$64,793
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
T Cell Alternative p38 Activation Pathway
|
Z01 BC 010774
|
$431,955
|
$215,978
|
Ashwell, Jonathan
|
CCR (NCI)
|
|
Syk and associated proteins in breast cancer
|
3R01CA115465-02S1
|
$36,106
|
$9,027
|
GEAHLEN, ROBERT
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
|
Syk and associated proteins in breast cancer
|
5R01CA115465-02
|
$253,034
|
$63,259
|
GEAHLEN, ROBERT
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
|
Subpopulations of Human Dendritic Cells
|
5R01CA078846-10
|
$292,811
|
$73,203
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
Stanford University Cancer Center
|
3P30CA124435-02S1
|
$80,833
|
$808
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Stanford University Cancer Center
|
5P30CA124435-02
|
$1,572,967
|
$15,730
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S1
|
$115,875
|
$3,476
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S2
|
$247,200
|
$7,416
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S3
|
$92,700
|
$2,781
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-24S4
|
$76,478
|
$2,294
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
5P30CA023100-24
|
$4,005,660
|
$120,170
|
CARSON, DENNIS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
SIGNAL TRANSDUCTION AND CELL DEATH REGULATION
|
5P01CA069381-13
|
$1,715,290
|
$343,058
|
REED, JOHN
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
Signal integration of the death receptor pathways
|
5R01CA083817-08
|
$218,579
|
$109,290
|
YIN, XIAO-MING
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Roswell Park Cancer Institute Center Support Grant
|
2P30CA016056-32
|
$4,168,904
|
$125,067
|
TRUMP, DONALD
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Roswell Park Cancer Institute Center Support Grant
|
3P30CA016056-32S1
|
$117,279
|
$3,518
|
TRUMP, DONALD
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Role of T regulatory suppression in autoimmunity and cancer
|
Z01 BC 010707
|
$274,064
|
$54,813
|
Oppenheim, Joost
|
CCR (NCI)
|
|
Role of Mast Cells in Inflammation and Immunity
|
5R01CA072074-24
|
$401,136
|
$401,136
|
GALLI, STEPHEN
|
STANFORD UNIVERSITY
|
|
Role of Kupffer Cell in Hepatic Carcinogenesis
|
5R01CA100908-04
|
$226,529
|
$113,265
|
KLAUNIG, JAMES
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Role of inflammation, innate resistance, and immunity in carcinogenesis.
|
Z01 BC 010793
|
$1,811,466
|
$543,440
|
Trinchieri, Giorgio
|
CCR (NCI)
|
|
Role of Epstein-Barr virus LMP1 in lymphoma
|
5R01CA106159-04
|
$218,727
|
$109,364
|
IZUMI, KENNETH
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
Total relevant funding to Tumor Necrosis Factor for this search: $26,007,370
|